{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:39:59Z","timestamp":1792226399328,"version":"4.4.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":57,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["AAP2008983"],"award-info":[{"award-number":["AAP2008983"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2001692"],"award-info":[{"award-number":["APP2001692"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007844","name":"National Sun Yat-sen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.aohep.2025.101896","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T12:44:04Z","timestamp":1741265044000},"page":"101896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Energy metabolism: An emerging therapeutic frontier in liver fibrosis"],"prefix":"10.1016","volume":"30","author":[{"given":"Iram","family":"Irshad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Ikejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Lung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Romero-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Eslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.aohep.2025.101896_bib0001","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.aohep.2025.101896_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101512","article-title":"MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease","volume":"29","author":"Pan","year":"2024","journal-title":"Ann. Hepatol."},{"issue":"4","key":"10.1016\/j.aohep.2025.101896_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(22)00047-X","article-title":"Chronic liver diseases must be reduced worldwide: it is time to act","volume":"10","author":"Vento","year":"2022","journal-title":"Lancet Glob. Health"},{"issue":"7","key":"10.1016\/j.aohep.2025.101896_bib0004","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.socscimed.2006.04.018","article-title":"Health care costs in the last year of life\u2014the Dutch experience","volume":"63","author":"Polder","year":"2006","journal-title":"Soc. Sci. Med."},{"issue":"3","key":"10.1016\/j.aohep.2025.101896_bib0005","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s12072-024-10673-7","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than MASLD","volume":"18","author":"Pan","year":"2024","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.aohep.2025.101896_bib0006","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cca.2020.03.024","article-title":"COX-2 in liver fibrosis","volume":"506","author":"Yang","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.aohep.2025.101896_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.06.010","article-title":"STAT3: a key regulator in liver fibrosis","volume":"21","author":"Zhao","year":"2021","journal-title":"Ann. Hepatol."},{"issue":"2","key":"10.1016\/j.aohep.2025.101896_bib0008","doi-asserted-by":"crossref","first-page":"e0026","DOI":"10.1097\/HC9.0000000000000026","article-title":"The burden of liver cirrhosis and underlying etiologies: results from the Global Burden of Disease Study 2019","volume":"7","author":"Lan","year":"2023","journal-title":"Hepatol. Commun."},{"issue":"741","key":"10.1016\/j.aohep.2025.101896_bib0009","doi-asserted-by":"crossref","first-page":"eadj0133","DOI":"10.1126\/scitranslmed.adj0133","article-title":"Inhibition of MERTK reduces organ fibrosis in mouse models of fibrotic disease","volume":"16","author":"Pan","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"16","key":"10.1016\/j.aohep.2025.101896_bib0010","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3748\/wjg.v26.i16.1861","article-title":"Macrophages in metabolic associated fatty liver disease","volume":"26","author":"Alharthi","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.aohep.2025.101896_bib0011","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.tig.2020.03.003","article-title":"The epigenetic drug discovery landscape for metabolic-associated fatty liver disease","volume":"36","author":"Bayoumi","year":"2020","journal-title":"Trends. Genet."},{"key":"10.1016\/j.aohep.2025.101896_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103521","article-title":"Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver disease","volume":"70","author":"Metwally","year":"2021","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.aohep.2025.101896_bib0013","first-page":"1599","article-title":"Bioenergetics of the fibrosis","volume":"86","author":"Yakupova","year":"2021","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0014","doi-asserted-by":"crossref","first-page":"e1499","DOI":"10.1002\/wsbm.1499","article-title":"Liver fibrosis: pathophysiology and clinical implications","volume":"13","author":"Berumen","year":"2021","journal-title":"WIREs. Mech. Dis."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","article-title":"Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology","volume":"17","author":"Eslam","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.aohep.2025.101896_bib0016","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1535370219898141","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar","year":"2020","journal-title":"Exp. Biol. Med."},{"issue":"6","key":"10.1016\/j.aohep.2025.101896_bib0017","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1053\/j.gastro.2020.01.027","article-title":"Identification of lineage-specific transcription factors that prevent activation of hepatic stellate cells and promote fibrosis resolution","volume":"158","author":"Liu","year":"2020","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.aohep.2025.101896_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030581","article-title":"High risk of hepatocellular carcinoma development in fibrotic liver: role of the hippo-YAP\/TAZ signaling pathway","volume":"20","author":"Moon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.aohep.2025.101896_bib0019","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.3748\/wjg.v23.i13.2330","article-title":"Notch signaling mediated by TGF-\u03b2\/Smad pathway in concanavalin A-induced liver fibrosis in rats","volume":"23","author":"Wang","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0020","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/s41598-018-35736-2","article-title":"A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-\u03b21 dependent mechanisms","volume":"9","author":"Sharkawy","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.aohep.2025.101896_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115467","article-title":"Energy metabolism: a newly emerging target of BMP signaling in bone homeostasis","volume":"138","author":"Yang","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.aohep.2025.101896_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104714","article-title":"Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases","volume":"94","author":"Dewidar","year":"2023","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0023","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1083\/jcb.201606069","article-title":"Mitochondrial lipid transport and biosynthesis: a complex balance","volume":"214","author":"Mesmin","year":"2016","journal-title":"J. Cell Biol."},{"issue":"167","key":"10.1016\/j.aohep.2025.101896_bib0024","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004700","article-title":"Therapy for fibrotic diseases: nearing the starting line","volume":"5","author":"Friedman","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"42","key":"10.1016\/j.aohep.2025.101896_bib0025","doi-asserted-by":"crossref","first-page":"25427","DOI":"10.1074\/jbc.M115.646984","article-title":"Metabolic reprogramming is required for myofibroblast contractility and differentiation","volume":"290","author":"Bernard","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0026","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/j.2040-4603.2014.tb00548.x","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"issue":"3","key":"10.1016\/j.aohep.2025.101896_bib0027","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jcsm.12178","article-title":"Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue","volume":"8","author":"Boengler","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"8","key":"10.1016\/j.aohep.2025.101896_bib0028","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.tcb.2016.03.002","article-title":"Chatty mitochondria: keeping balance in cellular protein homeostasis","volume":"26","author":"Topf","year":"2016","journal-title":"Trends. Cell Biol."},{"issue":"12","key":"10.1016\/j.aohep.2025.101896_bib0029","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00109-016-1451-y","article-title":"Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK\/NOX4\/ROS pathway","volume":"94","author":"He","year":"2016","journal-title":"J. Mol. Med. (Berl)"},{"issue":"3","key":"10.1016\/j.aohep.2025.101896_bib0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1152\/physiol.00046.2014","article-title":"Macrophages in kidney injury, inflammation, and fibrosis","volume":"30","author":"Cao","year":"2015","journal-title":"Physiology"},{"key":"10.1016\/j.aohep.2025.101896_bib0031","doi-asserted-by":"crossref","first-page":"4","DOI":"10.21037\/tgh-20-125","article-title":"Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease","volume":"6","author":"Prasun","year":"2021","journal-title":"Transl. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0032","first-page":"3","article-title":"Mitochondrial electron transport chain, ROS generation and uncoupling (Review)","volume":"44","author":"Zhao","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0033","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s44194-024-00032-x","article-title":"Mitochondrial homeostasis: shaping health and disease","volume":"3","author":"Li","year":"2024","journal-title":"Curr. Med."},{"issue":"6","key":"10.1016\/j.aohep.2025.101896_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065785","article-title":"The Drp1-mediated mitochondrial fission protein interactome as an emerging core player in mitochondrial dynamics and cardiovascular disease therapy","volume":"24","author":"Zerihun","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.aohep.2025.101896_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111035","article-title":"Mitochondrial quality control in liver fibrosis: epigenetic hallmarks and therapeutic strategies","volume":"115","author":"Jia","year":"2024","journal-title":"Cell Signal."},{"issue":"4","key":"10.1016\/j.aohep.2025.101896_bib0036","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1152\/advan.00052.2006","article-title":"PGC-1alpha: a key regulator of energy metabolism","volume":"30","author":"Liang","year":"2006","journal-title":"Adv. Physiol. Educ."},{"issue":"5","key":"10.1016\/j.aohep.2025.101896_bib0037","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s10620-015-4025-x","article-title":"Function of autophagy in nonalcoholic fatty liver disease","volume":"61","author":"Czaja","year":"2016","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.aohep.2025.101896_bib0038","first-page":"5747","article-title":"The role of autophagy in hepatic fibrosis","volume":"13","author":"Sun","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0039","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/tra.12617","article-title":"The metabolic signaling hub","volume":"20","author":"Lamming","year":"2019","journal-title":"Traffic."},{"issue":"5","key":"10.1016\/j.aohep.2025.101896_bib0040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.cmet.2011.04.004","article-title":"Autophagy in the cellular energetic balance","volume":"13","author":"Singh","year":"2011","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13010101","article-title":"Metabolic role of autophagy in the pathogenesis and development of NAFLD","volume":"13","author":"An","year":"2023","journal-title":"Metabolites."},{"issue":"4","key":"10.1016\/j.aohep.2025.101896_bib0042","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2010.04.009","article-title":"Mitochondria supply membranes for autophagosome biogenesis during starvation","volume":"141","author":"Hailey","year":"2010","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.aohep.2025.101896_bib0043","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1038\/emboj.2011.104","article-title":"Mitochondria regulate autophagy by conserved signalling pathways","volume":"30","author":"Graef","year":"2011","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0044","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41419-021-04469-y","article-title":"BNIP3L\/NIX-mediated mitophagy: molecular mechanisms and implications for human disease","volume":"13","author":"Li","year":"2021","journal-title":"Cell Death. Dis."},{"issue":"2","key":"10.1016\/j.aohep.2025.101896_bib0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.aohep.2025.101896_bib0046","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.3390\/cells10123604","article-title":"Metabolic reprogramming of liver fibrosis","volume":"10","author":"Delgado","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.aohep.2025.101896_bib0047","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jcmgh.2023.02.010","article-title":"Hepatic stellate cells: dictating outcome in nonalcoholic fatty liver disease","volume":"15","author":"Wiering","year":"2023","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.aohep.2025.101896_bib0048","doi-asserted-by":"crossref","first-page":"e34945","DOI":"10.1371\/journal.pone.0034945","article-title":"Replacement of retinyl esters by polyunsaturated triacylglycerol species in lipid droplets of hepatic stellate cells during activation","volume":"7","author":"Testerink","year":"2012","journal-title":"PLoS. One"},{"issue":"7","key":"10.1016\/j.aohep.2025.101896_bib0049","doi-asserted-by":"crossref","DOI":"10.3390\/nu14071456","article-title":"Retinoids in the pathogenesis and treatment of liver diseases","volume":"14","author":"Melis","year":"2022","journal-title":"Nutrients."},{"issue":"5 Pt 1","key":"10.1016\/j.aohep.2025.101896_bib0050","first-page":"G947","article-title":"Retinol release by activated rat hepatic lipocytes: regulation by Kupffer cell-conditioned medium and PDGF","volume":"264","author":"Friedman","year":"1993","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0051","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.aohep.2025.101896_bib0052","doi-asserted-by":"crossref","DOI":"10.1007\/s12072-024-10774-3","article-title":"The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease","author":"Eslam","year":"2025","journal-title":"Hepatol. Int."},{"issue":"7","key":"10.1016\/j.aohep.2025.101896_bib0053","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.aohep.2025.101896_bib0054","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1053\/j.gastro.2012.07.115","article-title":"Hedgehog controls hepatic stellate cell fate by regulating metabolism","volume":"143","author":"Chen","year":"2012","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.aohep.2025.101896_bib0055","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.aohep.2025.101896_bib0056","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/jcmm.13501","article-title":"Elevated mitochondrial activity distinguishes fibrogenic hepatic stellate cells and sensitizes for selective inhibition by mitotropic doxorubicin","volume":"22","author":"Gajendiran","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"6","key":"10.1016\/j.aohep.2025.101896_bib0057","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jhep.2014.02.014","article-title":"A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease","volume":"60","author":"Nishikawa","year":"2014","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.aohep.2025.101896_bib0058","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.aohep.2025.101896_bib0059","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.redox.2015.09.009","article-title":"Reciprocal regulation of TGF-\u03b2 and reactive oxygen species: a perverse cycle for fibrosis","volume":"6","author":"Liu","year":"2015","journal-title":"Redox. Biol."},{"key":"10.1016\/j.aohep.2025.101896_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3809308","article-title":"Recent insights into the mitochondrial role in autophagy and its regulation by oxidative stress","volume":"2019","author":"Roca-Agujetas","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"issue":"8","key":"10.1016\/j.aohep.2025.101896_bib0061","doi-asserted-by":"crossref","first-page":"e43003","DOI":"10.1371\/journal.pone.0043003","article-title":"Mitochondrial function in permeabilized cardiomyocytes is largely preserved in the senescent rat myocardium","volume":"7","author":"Picard","year":"2012","journal-title":"PLoS. One"},{"issue":"12","key":"10.1016\/j.aohep.2025.101896_bib0062","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.biocel.2004.02.002","article-title":"Regulation and role of autophagy in mammalian cells","volume":"36","author":"Meijer","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.aohep.2025.101896_bib0063","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","article-title":"Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues","volume":"142","author":"Hern\u00e1ndez-Gea","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.aohep.2025.101896_bib0064","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbrc.2014.10.076","article-title":"Hypoxia-inducible factor-1alpha regulates autophagy to activate hepatic stellate cells","volume":"454","author":"Deng","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.aohep.2025.101896_bib0065","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3892\/mmr.2014.2383","article-title":"Transforming growth factor\u2011\u03b21 reduces apoptosis via autophagy activation in hepatic stellate cells","volume":"10","author":"Fu","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"11","key":"10.1016\/j.aohep.2025.101896_bib0066","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119681","article-title":"PNPLA3-I148M variant promotes the progression of liver fibrosis by inducing mitochondrial dysfunction","volume":"24","author":"Gou","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.aohep.2025.101896_bib0067","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12072-015-9689-y","article-title":"Genetic and epigenetic mechanisms of NASH","volume":"10","author":"Eslam","year":"2016","journal-title":"Hepatol. Int."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0068","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jcb.27378","article-title":"PNPLA3 variant M148 causes resistance to starvation-mediated lipid droplet autophagy in human hepatocytes","volume":"120","author":"Negoita","year":"2019","journal-title":"J. Cell Biochem."},{"issue":"11","key":"10.1016\/j.aohep.2025.101896_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2023.10.008","article-title":"The I148M variant increases ketogenesis and decreases hepatic lipogenesis and mitochondrial function in humans","volume":"35","author":"Luukkonen","year":"2023","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.aohep.2025.101896_bib0070","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jhep.2022.03.031","article-title":"Rare ATG7 genetic variants predispose patients to severe fatty liver disease","volume":"77","author":"Baselli","year":"2022","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.aohep.2025.101896_bib0071","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.aohep.2025.101896_bib0072","doi-asserted-by":"crossref","first-page":"e28808","DOI":"10.1016\/j.heliyon.2024.e28808","article-title":"Mitochondrial complex I subunit MT-ND1 mutations affect disease progression","volume":"10","author":"Lin","year":"2024","journal-title":"Heliyon."},{"issue":"5","key":"10.1016\/j.aohep.2025.101896_bib0073","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1080\/15548627.2022.2139080","article-title":"PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models","volume":"19","author":"Han","year":"2023","journal-title":"Autophagy."},{"key":"10.1016\/j.aohep.2025.101896_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155583","article-title":"Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogramming","volume":"144","author":"Alharthi","year":"2023","journal-title":"Metabolism."},{"key":"10.1016\/j.aohep.2025.101896_bib0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mito.2022.07.005","article-title":"Epigenetic control of mitochondrial fission enables hepatic stellate cells activation in liver fibrosis via PGC-1\u03b1-Drp1 pathway","volume":"66","author":"Yang","year":"2022","journal-title":"Mitochondrion."},{"issue":"9","key":"10.1016\/j.aohep.2025.101896_bib0076","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1002\/jcp.24054","article-title":"Metaboloepigenetics: interrelationships between energy metabolism and epigenetic control of gene expression","volume":"227","author":"Donohoe","year":"2012","journal-title":"J. Cell Physiol."},{"issue":"4","key":"10.1016\/j.aohep.2025.101896_bib0077","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0078","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jcmgh.2017.04.007","article-title":"Epigenetics and liver fibrosis","volume":"4","author":"Moran-Salvador","year":"2017","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"21","key":"10.1016\/j.aohep.2025.101896_bib0079","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1111\/bph.12590","article-title":"A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells","volume":"171","author":"Park","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.aohep.2025.101896_bib0080","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/B978-0-12-814118-2.00005-7","article-title":"Chapter 20 - role of sirtuins in liver diseases","author":"Ezhilarasan","year":"2021","journal-title":"Sirtuin Biology in Medicine"},{"issue":"2","key":"10.1016\/j.aohep.2025.101896_bib0081","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2015.02.049","article-title":"Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease","volume":"63","author":"Kitamoto","year":"2015","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.aohep.2025.101896_bib0082","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.cdd.4401979","article-title":"Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis","volume":"14","author":"Mann","year":"2007","journal-title":"Cell Death Differentiation"},{"issue":"3","key":"10.1016\/j.aohep.2025.101896_bib0083","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbrc.2015.10.101","article-title":"Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model","volume":"469","author":"Karthikeyan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.aohep.2025.101896_bib0084","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jpeds.2016.12.031","article-title":"Lactate and lactate: pyruvate ratio in the diagnosis and outcomes of pediatric acute liver failure","volume":"182","author":"Feldman","year":"2017","journal-title":"J. Pediatr."},{"issue":"8","key":"10.1016\/j.aohep.2025.101896_bib0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083899","article-title":"Nonalcoholic fatty liver disease: focus on new biomarkers and lifestyle interventions","volume":"22","author":"Notarnicola","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.aohep.2025.101896_bib0086","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mito.2020.12.010","article-title":"Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"57","author":"Ajaz","year":"2021","journal-title":"Mitochondrion."},{"key":"10.1016\/j.aohep.2025.101896_bib0087","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-230X-12-68","article-title":"Mitochondrial uncouplers inhibit hepatic stellate cell activation","volume":"12","author":"Guimar\u00e3es","year":"2012","journal-title":"BMC. Gastroenterol."},{"issue":"3","key":"10.1016\/j.aohep.2025.101896_bib0088","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbrc.2015.10.101","article-title":"Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model","volume":"469","author":"Karthikeyan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0089","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-230X-12-68","article-title":"Mitochondrial uncouplers inhibit hepatic stellate cell activation","volume":"12","author":"Guimar\u00e3es","year":"2012","journal-title":"BMC. Gastroenterol."},{"key":"10.1016\/j.aohep.2025.101896_bib0090","doi-asserted-by":"crossref","unstructured":"Lan T, Kisseleva T, Brenner DA. Deficiency of NOX1 or NOX4 prevents liver inflammation and fibrosis in mice through inhibition of hepatic stellate cell activation. PLoS. One 2015;10(7). https:\/\/doi.org\/ARTNe012974310.1371\/journal.pone.0129743.","DOI":"10.1371\/journal.pone.0129743"},{"issue":"4","key":"10.1016\/j.aohep.2025.101896_bib0091","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/jcmm.17649","article-title":"Pre-clinical evidence of a dual NADPH oxidase 1\/4 inhibitor (setanaxib) in liver, kidney and lung fibrosis","volume":"27","author":"Thannickal","year":"2023","journal-title":"J. Cell Mol. Med."},{"issue":"39","key":"10.1016\/j.aohep.2025.101896_bib0092","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202404658","article-title":"The dual-target nanoparticles with ROS sensitivity inhibit the hedgehog signaling pathway and decrease oxidative stress in activated hepatic stellate cells to alleviate liver fibrosis","volume":"34","author":"Zhang","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0093","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbrc.2016.06.018","article-title":"Tetrandrine induces lipid accumulation through blockade of autophagy in a hepatic stellate cell line","volume":"477","author":"Miyamae","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.aohep.2025.101896_bib0094","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jhep.2011.07.010","article-title":"A role for autophagy during hepatic stellate cell activation","volume":"55","author":"Thoen","year":"2011","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.aohep.2025.101896_bib0095","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1248\/bpb.b14-00297","article-title":"Chloroquine improved carbon tetrachloride-induced liver fibrosis through its inhibition of the activation of hepatic stellate cells: role of autophagy","volume":"37","author":"He","year":"2014","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0096","doi-asserted-by":"crossref","first-page":"9289","DOI":"10.1038\/s41598-017-09673-5","article-title":"Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-\u03b21\/Smads and PI3K\/Akt pathways","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.aohep.2025.101896_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108117","article-title":"The regulatory role and mechanism of autophagy in energy metabolism-related hepatic fibrosis","volume":"234","author":"Hou","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0098","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12964-019-0324-8","article-title":"Blockade of glycolysis-dependent contraction by oroxylin a via inhibition of lactate dehydrogenase-a in hepatic stellate cells","volume":"17","author":"Wang","year":"2019","journal-title":"Cell Commun. Signal."},{"issue":"6478","key":"10.1016\/j.aohep.2025.101896_bib0099","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay0542","article-title":"An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis","volume":"367","author":"Zhao","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.aohep.2025.101896_bib0100","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cmet.2014.07.012","article-title":"FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss","volume":"20","author":"Owen","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.aohep.2025.101896_bib0101","doi-asserted-by":"crossref","unstructured":"Bayoumi A, Elsayed A, Han SL, Petta S, Adams LA, Aller R, et al. Mistranslation drives alterations in protein levels and the effects of a synonymous variant at the fibroblast growth factor 21 locus. Adv. Sci. 2021;8(11). https:\/\/doi.org\/ARTN200416810.1002\/advs.202004168.","DOI":"10.1002\/advs.202004168"},{"issue":"3","key":"10.1016\/j.aohep.2025.101896_bib0107","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1124\/jpet.121.000786","article-title":"Selective acetyl-CoA carboxylase 1 inhibitor improves hepatic steatosis and hepatic fibrosis in a preclinical nonalcoholic steatohepatitis model","volume":"379","author":"Tamura","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.aohep.2025.101896_bib0108","doi-asserted-by":"crossref","first-page":"15661","DOI":"10.1038\/s41598-022-19459-z","article-title":"FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models","volume":"12","author":"O'Farrell","year":"2022","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.aohep.2025.101896_bib0109","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cmet.2022.05.004","article-title":"Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia","volume":"34","author":"Morrow","year":"2022","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.aohep.2025.101896_bib0110","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1194\/jlr.R024794","article-title":"Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease","volume":"53","author":"Porez","year":"2012","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.aohep.2025.101896_bib113","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/jcmm.17649","article-title":"Pre-clinical evidence of a dual NADPH oxidase 1\/4 inhibitor (setanaxib) in liver, kidney and lung fibrosis","volume":"27","author":"Thannickal","year":"2023","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.aohep.2025.101896_bib0111","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/HEP.0000000000000456","article-title":"Current challenges and future perspectives in treating patients with NAFLD-related cirrhosis","volume":"80","author":"Mallet","year":"2024","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.aohep.2025.101896_bib0112","first-page":"304","article-title":"Antihepatic fibrosis drugs in clinical trials","volume":"8","author":"Guo","year":"2020","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.aohep.2025.101896_bib0102","doi-asserted-by":"crossref","unstructured":"Tan Z, Sun HB, Xue TX, Gan CL, Liu HY, Xie YT, et al. Liver fibrosis: therapeutic targets and advances in drug therapy. Front. Cell Dev. Biol. 2021;9. https:\/\/doi.org\/ARTN73017610.3389\/fcell.2021.730176.","DOI":"10.3389\/fcell.2021.730176"},{"issue":"7","key":"10.1016\/j.aohep.2025.101896_bib0103","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tips.2019.05.002","article-title":"Genetic insights for drug development in NAFLD","volume":"40","author":"Eslam","year":"2019","journal-title":"Trends. Pharmacol. Sci."},{"key":"10.1016\/j.aohep.2025.101896_bib0104","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.coph.2021.07.007","article-title":"An update on drug development for the treatment of metabolic (dysfunction) associated fatty liver disease: progress and opportunities","volume":"60","author":"Pan","year":"2021","journal-title":"Curr. Opin. Pharmacol."},{"issue":"2","key":"10.1016\/j.aohep.2025.101896_bib0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","article-title":"The power of plasticity-metabolic regulation of hepatic stellate cells","volume":"33","author":"Trivedi","year":"2021","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.aohep.2025.101896_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbabio.2020.148276","article-title":"Cell energy metabolism: an update","volume":"1861","author":"Rigoulet","year":"2020","journal-title":"Biochim. Biophys. Acta Bioenerg."}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:40:11Z","timestamp":1778622011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268125001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1665268125001206"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.101896","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Energy metabolism: An emerging therapeutic frontier in liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.101896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101896"}}